Inclinix

Wilmington, United States Founded: 1999 • Age: 27 yrs Acquired By PMG Research
Customized solutions for clinical trial enrollment are provided.
Annual revenue - Latest available
Total funding $10.5M 2 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Inclinix

Inclinix is a company based in Wilmington (United States) founded in 1999 was acquired by PMG Research in June 2012. Inclinix has raised $10.5 million across 2 funding rounds from investors including PMG Research and Frontier Capital. Inclinix has completed 1 acquisition, including PMG Research. Inclinix operates in a competitive market with competitors including Elligo, Acurian, CenExel, ePatientFinder and Velocity Clinical Research, among others.

  • Headquarter Wilmington, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $10.5 M (USD)

    in 2 rounds

  • Latest Funding Round
    $500 K (USD), Series B

    Sep 29, 2010

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    PMG Research

    (Jun 04, 2012)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Inclinix

Inclinix has successfully raised a total of $10.5M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $500 thousand completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series B — $500,000
  • First Round

    (07 Jan 2008)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2010 Amount Series B - Inclinix Valuation

investors

Jan, 2008 Amount Series B - Inclinix Valuation Frontier Capital

Investors in Inclinix

Inclinix has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include PMG Research and Frontier Capital.

All
Venture Fund
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Integrated network of clinical research facilities
Founded Year Domain Location

Investments & Acquisitions by Inclinix

Inclinix has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include PMG Research.

Investments
Acquisitions
Company Name Description Domain Location Founded Year Amount
Integrated network of clinical research facilities
1979

Financial Statements - Inclinix

Inclinix Comparisons

+
Add Comparison
Available on Premium

Competitors of Inclinix

Inclinix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Elligo, Acurian, CenExel, ePatientFinder and Velocity Clinical Research, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Patient recruitment and site activation services are provided by Elligo.
domain founded_year HQ Location
Patient enrollment and retention solutions for clinical trials are offered.
domain founded_year HQ Location
Research site management and patient recruitment services are provided.
domain founded_year HQ Location
Clinical trial recruitment service company
domain founded_year HQ Location
Provider of site management and patient recruitment services

Latest news on Inclinix

PMG Research has been acquired by inclinix
Baileysouthwell11 years ago
Inclinix Merger Triples Revenue
Wilmingtonbiz14 years ago

Frequently Asked Questions about Inclinix

Inclinix was founded in 1999 and raised its 1st funding round 9 years after it was founded.

Inclinix is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.

Inclinix is a funded company, having raised a total of $10.5M across 2 funding rounds to date. The company's 1st funding round was a Series B of $10M, raised on Jan 07, 2008.

Inclinix, established in 1999, excels in providing healthcare solutions, biopharma outsourcing, cro, clinical development, functional services, and research site and patient recruitment. Customized clinical trial enrollment solution. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Inclinix's top competitors include Velocity Clinical Research, Elligo and Acurian.

Inclinix has made 1 acquisition, including PMG Research.

Inclinix has 2 investors. Key investors include PMG Research, and Frontier Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available